应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02005 石四药集团
未开盘 03-19 16:08:15
2.460
-0.050
-1.99%
最高
2.480
最低
2.430
成交量
662.60万
今开
2.480
昨收
2.510
日振幅
1.99%
总市值
71.32亿
流通市值
71.32亿
总股本
28.99亿
成交额
1,626万
换手率
0.23%
流通股本
28.99亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
石四药集团(02005):氯化钙获国家药监局批准登记成为在上市制剂使用的原料药
智通财经 · 03-19 16:32
石四药集团(02005):氯化钙获国家药监局批准登记成为在上市制剂使用的原料药
石四药集团(02005):布美他尼已获国家药监局批准登记成为在上市制剂使用的原料药
智通财经 · 03-16
石四药集团(02005):布美他尼已获国家药监局批准登记成为在上市制剂使用的原料药
石四药集团(02005):大容量生理氯化钠溶液(3000ml:27g)已获国家药监局批准关联申报采用江苏博生医用新材料生产的三层共挤输液用管作为药包材
智通财经 · 03-13
石四药集团(02005):大容量生理氯化钠溶液(3000ml:27g)已获国家药监局批准关联申报采用江苏博生医用新材料生产的三层共挤输液用管作为药包材
每日卖空追踪 | 石四药集团 03月12日卖空量成交33万股,卖空比例为8.34%
市场透视 · 03-12
每日卖空追踪 | 石四药集团 03月12日卖空量成交33万股,卖空比例为8.34%
每日卖空追踪 | 石四药集团 03月09日卖空量成交101.6万股,卖空比例为9.59%
市场透视 · 03-09
每日卖空追踪 | 石四药集团 03月09日卖空量成交101.6万股,卖空比例为9.59%
石四药集团03月09日主力净流出97.8万元 散户资金买入
市场透视 · 03-09
石四药集团03月09日主力净流出97.8万元 散户资金买入
石四药集团(02005)已取得有关注射用左亚叶酸钙(25mg)的药品生产注册批件
智通财经 · 03-06
石四药集团(02005)已取得有关注射用左亚叶酸钙(25mg)的药品生产注册批件
每日卖空追踪 | 石四药集团 03月05日卖空量成交437.6万股,卖空比例为15.38%
市场透视 · 03-05
每日卖空追踪 | 石四药集团 03月05日卖空量成交437.6万股,卖空比例为15.38%
每日卖空追踪 | 石四药集团 03月04日卖空量成交501万股,卖空比例为17.47%
市场透视 · 03-04
每日卖空追踪 | 石四药集团 03月04日卖空量成交501万股,卖空比例为17.47%
石四药集团03月03日主力净流出224.7万元 散户资金买入
市场透视 · 03-03
石四药集团03月03日主力净流出224.7万元 散户资金买入
石四药集团盘中异动 下午盘股价大跌5.02%报2.460港元
市场透视 · 03-03
石四药集团盘中异动 下午盘股价大跌5.02%报2.460港元
石四药集团(02005):取得盐酸多沙普仑注射液(5ml:100mg)的药品生产注册批件
智通财经 · 03-03
石四药集团(02005):取得盐酸多沙普仑注射液(5ml:100mg)的药品生产注册批件
石四药集团(02005)2026年2月股份变动月报表:股本维持稳定
公告速递 · 03-02
石四药集团(02005)2026年2月股份变动月报表:股本维持稳定
每日卖空追踪 | 石四药集团 03月02日卖空量成交193.6万股,卖空比例为8.63%
市场透视 · 03-02
每日卖空追踪 | 石四药集团 03月02日卖空量成交193.6万股,卖空比例为8.63%
港股异动 | 石四药集团(02005)再跌超4% 两款原料药获批上市 此前预计全年纯利最多跌六成
智通财经 · 03-02
港股异动 | 石四药集团(02005)再跌超4% 两款原料药获批上市 此前预计全年纯利最多跌六成
石四药集团重组胶原妇科凝胶与B型钠尿肽检测试剂盒获医疗器械注册证
美股速递 · 02-27
石四药集团重组胶原妇科凝胶与B型钠尿肽检测试剂盒获医疗器械注册证
石四药集团(02005):甲氧氯普胺及盐酸甲氧氯普胺获国家药监局批准登记成为在上市制剂使用的原料药
智通财经 · 02-27
石四药集团(02005):甲氧氯普胺及盐酸甲氧氯普胺获国家药监局批准登记成为在上市制剂使用的原料药
每日卖空追踪 | 石四药集团 02月26日卖空量成交187.6万股,卖空比例为8.16%
市场透视 · 02-26
每日卖空追踪 | 石四药集团 02月26日卖空量成交187.6万股,卖空比例为8.16%
石四药集团02月26日遭主力抛售1145.2万元
市场透视 · 02-26
石四药集团02月26日遭主力抛售1145.2万元
港股异动 | 石四药集团(02005)午后跌超5% 预计2025年度纯利同比下降45%-60%
智通财经 · 02-26
港股异动 | 石四药集团(02005)午后跌超5% 预计2025年度纯利同比下降45%-60%
加载更多
公司概况
公司名称:
石四药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石四药集团有限公司,前称为利君国际医药(控股)有限公司,是一家主要从事研究、开发、制造及向医院及分销商销售药物产品的投资控股公司。公司的产品主要包括静脉输液的成药、原料药及医用材料。该公司的产品主要包括非聚氯乙烯软袋输液、聚丙烯塑瓶输液和玻璃瓶输液。该公司的产品还包括盐酸倍他司汀、盐酸氨溴索、盐酸罗哌卡因和多索茶碱以及原料药,包括咖啡因、茶碱、氨茶碱、甲硝唑和硝苯地平。
发行价格:
--
{"stockData":{"symbol":"02005","market":"HK","secType":"STK","nameCN":"石四药集团","latestPrice":2.46,"timestamp":1773907695002,"preClose":2.51,"halted":0,"volume":6626000,"delay":0,"changeRate":-0.019920318725099532,"floatShares":2899000000,"shares":2899000000,"eps":0.358192,"marketStatus":"未开盘","change":-0.05,"latestTime":"03-19 16:08:15","open":2.48,"high":2.48,"low":2.43,"amount":16262380,"amplitude":0.01992,"askPrice":2.46,"askSize":718000,"bidPrice":2.45,"bidSize":90000,"shortable":3,"etf":0,"ttmEps":0.223096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":0,"adr":0,"listingDate":1135008000000,"exchange":"SEHK","adjPreClose":2.51,"dividendRate":0.058943,"openAndCloseTimeList":[[1773883800000,1773892800000],[1773896400000,1773907200000]],"volumeRatio":1.285204,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02005","defaultTab":"news","newsList":[{"id":"2620488622","title":"石四药集团(02005):氯化钙获国家药监局批准登记成为在上市制剂使用的原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2620488622","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620488622?lang=zh_cn&edition=full","pubTime":"2026-03-19 16:32","pubTimestamp":1773909153,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,集团的氯化钙已获中国国家药品监督管理局批准登记成为在上市制剂使用的原料药。氯化钙作为一种静脉注射液添加药物,主要用于治疗钙缺乏、手足搐搦症、维生素D缺乏症和过敏性疾患,以及用于镁中毒、氟中毒和心功能异常(高血钾、低血钙或钙通道阻滞引起)的解救。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02005","BK1191","LU2460026573.USD"],"gpt_icon":0},{"id":"2619435161","title":"石四药集团(02005):布美他尼已获国家药监局批准登记成为在上市制剂使用的原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2619435161","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619435161?lang=zh_cn&edition=full","pubTime":"2026-03-16 12:14","pubTimestamp":1773634468,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,本集团的布美他尼已获中国国家药品监督管理局批准登记成为在上市制剂使用的原料药。布美他尼是一种袢利尿剂,主要用于治疗与心力衰竭以及肾、肝功能失调相关的水肿,也用于预防急性肾功能衰竭及治疗高血压、高钾血症及高钙血症、稀释性低钠血症、抗利尿激素分泌过多症(SIADH)及急性药物毒物中毒等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005):布美他尼已获国家药监局批准登记成为在上市制剂使用的原料药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU2460026573.USD","02005"],"gpt_icon":0},{"id":"2619162174","title":"石四药集团(02005):大容量生理氯化钠溶液(3000ml:27g)已获国家药监局批准关联申报采用江苏博生医用新材料生产的三层共挤输液用管作为药包材","url":"https://stock-news.laohu8.com/highlight/detail?id=2619162174","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619162174?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:34","pubTimestamp":1773390849,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,本集团的大容量生理氯化钠溶液(3000ml:27g)已获中国国家药品监督管理局批准关联申报采用江苏博生医用新材料股份有限公司(本集团内子公司)生产的三层共挤输液用管作为药包材。目前,由于冲洗液、透析液等大规格输液产品对安全性、稳定性及临床使用的特殊性有严格要求和标准,其所需的高性能输液袋软管全部依赖进口。本公司相信,此次获批标志着三层共挤输液用管已成功实现国产化替代,展现了本集团在药包材领域的自主创新突破,预期对本集团的业务带来正面影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02005","159703","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2619168224","title":"每日卖空追踪 | 石四药集团 03月12日卖空量成交33万股,卖空比例为8.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619168224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619168224?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304227,"startTime":"0","endTime":"0","summary":"石四药集团北京时间03月12日,跌1.19%,卖空量成交33万股,较上一交易日减少77.88%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163332a6ba50c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163332a6ba50c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2618646603","title":"每日卖空追踪 | 石四药集团 03月09日卖空量成交101.6万股,卖空比例为9.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618646603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618646603?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045027,"startTime":"0","endTime":"0","summary":"石四药集团北京时间03月09日,股价较前一交易日持平,卖空量成交101.6万股,较上一交易日减少92.38%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163328a6b1c71c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163328a6b1c71c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2618660362","title":"石四药集团03月09日主力净流出97.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618660362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618660362?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:15","pubTimestamp":1773044158,"startTime":"0","endTime":"0","summary":"03月09日,石四药集团股价收平报2.51元,成交金额2613.8万元,换手率0.37%,振幅3.98%,量比0.28。石四药集团今日主力资金净流出97.8万元,上一交易日主力净流入2438.5万元。该股近5个交易日下跌2.70%,主力资金累计净流入3101.9万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2894.3万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309162115a45ad96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309162115a45ad96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","LU2460026573.USD","02005"],"gpt_icon":0},{"id":"2617853501","title":"石四药集团(02005)已取得有关注射用左亚叶酸钙(25mg)的药品生产注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2617853501","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617853501?lang=zh_cn&edition=full","pubTime":"2026-03-06 12:01","pubTimestamp":1772769706,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)公布,集团已取得中国国家药品监督管理局有关注射用左亚叶酸钙(25mg)的药品生产注册批件,属于化学药品第3类,视同通过一致性评价。左亚叶酸钙主要与5-氟尿嘧啶合用,用于治疗胃癌和结直肠癌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005)已取得有关注射用左亚叶酸钙(25mg)的药品生产注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2617570579","title":"每日卖空追踪 | 石四药集团 03月05日卖空量成交437.6万股,卖空比例为15.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617570579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617570579?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699427,"startTime":"0","endTime":"0","summary":"石四药集团北京时间03月05日,跌2.07%,卖空量成交437.6万股,较上一交易日减少62.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163325a44ef769&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163325a44ef769&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2616339735","title":"每日卖空追踪 | 石四药集团 03月04日卖空量成交501万股,卖空比例为17.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616339735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616339735?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613026,"startTime":"0","endTime":"0","summary":"石四药集团北京时间03月04日,跌2.03%,卖空量成交501万股,较上一交易日减少27.01%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163327a44a6ccf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163327a44a6ccf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02005","LU2460026573.USD"],"gpt_icon":0},{"id":"2616002329","title":"石四药集团03月03日主力净流出224.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616002329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616002329?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:16","pubTimestamp":1772525763,"startTime":"0","endTime":"0","summary":"03月03日, 石四药集团股价跌5.02%,报收2.46元,成交金额6369.9万元,换手率0.88%,振幅6.56%,量比1.51。石四药集团今日主力资金净流出224.7万元,上一交易日主力净流入505.1万元。该股近5个交易日下跌15.86%,主力资金累计净流出1266.5万元;近20日主力资金累计净流出575.8万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162152a69c9cc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162152a69c9cc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","LU2460026573.USD","02005"],"gpt_icon":0},{"id":"2616932902","title":"石四药集团盘中异动 下午盘股价大跌5.02%报2.460港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616932902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616932902?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:12","pubTimestamp":1772521927,"startTime":"0","endTime":"0","summary":"2026年03月03日下午盘15时12分,石四药集团股票出现异动,股价急速下跌5.02%。截至发稿,该股报2.460港元/股,成交量1876.07万股,换手率0.65%,振幅5.79%。资金方面,该股资金流入1009.44万港元,流出3165.61万港元。石四药集团股票所在的药品行业中,整体跌幅为1.24%。其相关个股中,天大药业、宝济药业-B、中智药业涨幅较大,振幅较大的相关个股有宝济药业-B、精优药业、九源基因,振幅分别为17.87%、14.29%、12.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303151207a4456e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303151207a4456e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","BK1191","LU2460026573.USD"],"gpt_icon":0},{"id":"2616392267","title":"石四药集团(02005):取得盐酸多沙普仑注射液(5ml:100mg)的药品生产注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2616392267","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616392267?lang=zh_cn&edition=full","pubTime":"2026-03-03 12:04","pubTimestamp":1772510684,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,集团已取得中国国家药品监督管理局有关盐酸多沙普仑注射液(5ml:100mg)的药品生产注册批件,属于化学药品第3类,视同通过一致性评价。集团的盐酸多沙普仑注射液是国内企业首家获批,主要用于治疗呼吸衰竭。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005):取得盐酸多沙普仑注射液(5ml:100mg)的药品生产注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02005","LU2460026573.USD"],"gpt_icon":0},{"id":"1168659826","title":"石四药集团(02005)2026年2月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1168659826","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168659826?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:40","pubTimestamp":1772440810,"startTime":"0","endTime":"0","summary":"石四药集团有限公司于2026年3月2日发布2026年2月股份变动月报表,报告期截至2026年2月28日。根据公告披露,公司本月无新增股份发行、购回或注销,整体股本结构保持不变。公司自公布日上月底至本月底,法定/注册股本维持为100亿股,面值每股0.02港元,总额约2亿港元。根据公告,公司已于2023年1月13日采纳的二零二三年购股权计划在本月无期权行使或变动,期末可行使期权对应股份数为297,268,338股。公告由执行董事兼公司秘书周兴扬签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"gpt_icon":0},{"id":"2616396927","title":"每日卖空追踪 | 石四药集团 03月02日卖空量成交193.6万股,卖空比例为8.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616396927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616396927?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440230,"startTime":"0","endTime":"0","summary":"石四药集团北京时间03月02日,跌4.07%,卖空量成交193.6万股,较上一交易日减少58.97%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163359a730c689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163359a730c689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"2616884753","title":"港股异动 | 石四药集团(02005)再跌超4% 两款原料药获批上市 此前预计全年纯利最多跌六成","url":"https://stock-news.laohu8.com/highlight/detail?id=2616884753","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616884753?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:53","pubTimestamp":1772434417,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,石四药集团再跌超4%,截至发稿,跌3.7%,报2.6港元,成交额4024.5万港元。消息面上,石四药集团公告,本集团的甲氧氯普胺及盐酸甲氧氯普胺已获中国国家药品监督管理局批准登记成为在上市制剂使用的原料药。值得注意的是,石四药集团预计2025年度溢利将较上年度的10.61亿港元下降45%至60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","BK4585","VXUS","BK1191","VT","BK4588","02005"],"gpt_icon":0},{"id":"1144127540","title":"石四药集团重组胶原妇科凝胶与B型钠尿肽检测试剂盒获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=1144127540","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144127540?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:33","pubTimestamp":1772181197,"startTime":"0","endTime":"0","summary":"石四药集团宣布,其医用重组胶原妇科凝胶及B型钠尿肽检测试剂盒已正式获得医疗器械注册证书。这两项产品的获批标志着公司在妇科与心血管诊断领域的技术实力得到进一步认可。重组胶原妇科凝胶采用创新生物技术,有望为妇科疾病治疗提供新方案;而B型钠尿肽检测试剂盒则用于心力衰竭的快速诊断,助力临床精准医疗。此次获批将拓宽石四药集团在医疗器械市场的布局,为未来业绩增长注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2614000686","title":"石四药集团(02005):甲氧氯普胺及盐酸甲氧氯普胺获国家药监局批准登记成为在上市制剂使用的原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2614000686","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614000686?lang=zh_cn&edition=full","pubTime":"2026-02-27 12:09","pubTimestamp":1772165363,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,本集团的甲氧氯普胺及盐酸甲氧氯普胺已获中国国家药品监督管理局批准登记成为在上市制剂使用的原料药。两款原料药属于多巴胺受体D2拮抗剂,同时还具有5-羟色胺4(5-HT4)受体激动效应,促进胃肠动力,主要用于止吐及治疗恶心、嗳气、胃部胀满、返流性食管炎等疾病。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"2614065480","title":"每日卖空追踪 | 石四药集团 02月26日卖空量成交187.6万股,卖空比例为8.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614065480","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614065480?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:30","pubTimestamp":1772094627,"startTime":"0","endTime":"0","summary":"石四药集团北京时间02月26日,跌5.34%,卖空量成交187.6万股,较上一交易日减少68.58%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163331a4cab4cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163331a4cab4cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02005","LU2460026573.USD"],"gpt_icon":0},{"id":"2614006594","title":"石四药集团02月26日遭主力抛售1145.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614006594","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614006594?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:15","pubTimestamp":1772093759,"startTime":"0","endTime":"0","summary":"02月26日, 石四药集团股价跌5.34%,报收2.66元,成交金额6202.4万元,换手率0.79%,振幅6.41%,量比2.70。石四药集团今日主力资金净流出1145.2万元,连续3日净流出,上一交易日主力净流出584.5万元。该股近5个交易日下跌11.92%,主力资金累计净流出1224.7万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出706.0万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162155a4caa65a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162155a4caa65a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2614451091","title":"港股异动 | 石四药集团(02005)午后跌超5% 预计2025年度纯利同比下降45%-60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614451091","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614451091?lang=zh_cn&edition=full","pubTime":"2026-02-26 14:47","pubTimestamp":1772088421,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,石四药集团(02005)午后跌超5%,截至发稿,跌5.34%,报2.66港元,成交额5290.44万港元。消息面上,石四药集团此前发布公告,预计2025年度溢利将较上年度的10.61亿港元下降45%-60%。主要由于2024年一季度国内流感爆发以致静脉输液及其他药品市场需求量旺盛,但截至2025年12月31日止的整个年度因国内没有大规模流行病发生叠加医保控费导致药品终端销量下降;各种形式的带量采购范围扩大以及国内外行业竞争加剧带来持续的价格压力;及盐酸溴己新安瓿注射液因不再通过国家药品集采销售而营业额有所减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7aeeed2b7873496584fe7f3c4e94617c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","VT","LU2460026573.USD","VXUS","02005","BK4585","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssygroup.com.hk","stockEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.1854},{"period":"3month","weight":-0.1689},{"period":"6month","weight":-0.1689},{"period":"1year","weight":-0.2511},{"period":"ytd","weight":-0.1307}],"compareEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0074},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0294},{"period":"ytd","weight":-0.0051}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石四药集团有限公司,前称为利君国际医药(控股)有限公司,是一家主要从事研究、开发、制造及向医院及分销商销售药物产品的投资控股公司。公司的产品主要包括静脉输液的成药、原料药及医用材料。该公司的产品主要包括非聚氯乙烯软袋输液、聚丙烯塑瓶输液和玻璃瓶输液。该公司的产品还包括盐酸倍他司汀、盐酸氨溴索、盐酸罗哌卡因和多索茶碱以及原料药,包括咖啡因、茶碱、氨茶碱、甲硝唑和硝苯地平。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.008314},{"month":2,"riseRate":0.52381,"avgChangeRate":0.02049},{"month":3,"riseRate":0.666667,"avgChangeRate":0.079064},{"month":4,"riseRate":0.5,"avgChangeRate":0.035812},{"month":5,"riseRate":0.45,"avgChangeRate":0.00985},{"month":6,"riseRate":0.5,"avgChangeRate":0.067908},{"month":7,"riseRate":0.35,"avgChangeRate":-0.027819},{"month":8,"riseRate":0.35,"avgChangeRate":-0.017769},{"month":9,"riseRate":0.3,"avgChangeRate":-0.04678},{"month":10,"riseRate":0.45,"avgChangeRate":-0.001982},{"month":11,"riseRate":0.65,"avgChangeRate":0.086372},{"month":12,"riseRate":0.5,"avgChangeRate":-0.009169}],"exchange":"SEHK","name":"石四药集团","nameEN":"SSY GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石四药集团(02005)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石四药集团(02005)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石四药集团,02005,石四药集团股票,石四药集团股票老虎,石四药集团股票老虎国际,石四药集团行情,石四药集团股票行情,石四药集团股价,石四药集团股市,石四药集团股票价格,石四药集团股票交易,石四药集团股票购买,石四药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石四药集团(02005)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石四药集团(02005)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}